Scientists embark on crucial study to save Britain's bees
Scientists from Kew Gardens are using a new study to track which trees bees prefer to try to stem the decline in our vital pollinators.
Bee populations are falling all over the world due to a mixture of habitat loss, climate change, and the use of pesticides, with a devastating impact on our biodiversity and food production.
But it's feared that not enough comprehensive, global research is being done to understand the issue or find solutions.
UK becoming a no-fly zone
Researchers based at Wakehurst in Sussex, known as Kew's "Wild Botanic Garden", have begun placing advanced bio-acoustics sensors in some of their trees to track which ones bees favour.
They hope it'll help urban planners know which trees to plant in built-up areas, as a way of combating the worrying decline in bee numbers.
Pollination research lead Dr Janine Griffiths-Lee said: "Nearly 90% of our flowering plants depend on the contribution of pollinators, but in the UK the population of flying insects in the last 20 years has decreased by around 60%.
"It's really hard to be able to put a figure on the decline of our pollinators, but we do know that globally the number is declining.
"And with that comes crop yield instability and the loss of an essential ecosystem service."
Their new, non-invasive monitors listen for the buzz created by bees' wing beats, building up heat maps of the most popular spots.
'We're facing twin crises'
Dr Griffiths-Lee said: "If you think about the tree's footprint, it's very small, but they're huge 3D structures covered in pollen and nectar, which are essential resources of pollinators.
"So we really wanted to think about which are the best trees for bees for us to plant, and that can inform landscape planners, urban architects."
Eight different species of tree were chosen for the study, including horse chestnut and lime trees, with a mixture of native and non-native species.
The scientists have also been gathering DNA from pollen, which also helps them to map which plants and flowers the insects prefer.
Wakehurst's director, Susan Raikes, calls the 535-acre estate a "living laboratory", and said the project's all about searching for nature-based solutions to the impacts of climate change.
"The stakes couldn't be higher, really. We know that we're facing these twin crises of biodiversity loss and climate change," she added.
"We need to be able to understand, as the climate changes, which plants from warmer climes will be good here in the UK for pollinators in the future.
"If all of our native plants are struggling, then we need to find new sources of pollen - for us all to survive."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
40 minutes ago
- The Independent
Cancer deaths drop by a fifth in 50 years – but cases are on the rise
Cancer death rates in the UK have seen a significant decline of over 20 per cent since the early 1970s, a new analysis reveals. According to a report by Cancer Research UK, while cancer diagnoses are on the rise, the likelihood of dying from the disease has decreased. The cancer death rate has fallen by approximately 22 per cent since 1973, dropping from 328 per 100,000 people to around 252 per 100,000 in 2023. This improvement is largely due to advancements in diagnosis and treatment, along with successful efforts to reduce smoking rates. However, the report also indicates that cancer diagnoses have increased by almost half (47 per cent) across Great Britain during the same period. The rate has risen from approximately 413 cases per 100,000 people to around 607 cases per 100,000 people. The study noted that "survival for all cancers combined in England and Wales has doubled since the early 1970s, but progress has slowed over the last 10 years and remains lower than other comparable countries," also stating that "survival increased three to five times faster in previous decades, compared with the improvement since 2010." Michelle Mitchell, Cancer Research UK's chief executive, said the findings show 'it is a time of both optimism and realism,' adding that it is also 'a golden age for cancer research.' The group's report cautions that, despite improvements in overall survival rates, the number of people being diagnosed with cancer has significantly increased compared to 50 years ago. Researchers identified smoking as the leading preventable cause of cancer, with obesity linked to 13 different types of the disease. Other risks include not using sunscreen or failing to cover up in the sun, sunbeds, alcohol, lack of exercise and diets high in processed meat. The report pointed out that around half of all new cancer diagnoses are in people aged 70 and over, but incidence rates are currently rising fastest in younger people. It said: 'In the UK, cancer incidence rates have increased by 23 per cent in people aged 20 to 49 since the early 1990s. 'However, population growth is concentrated in older age groups, so in terms of patient numbers, the biggest increase in cancer cases has been in older people.' The study also found that, on average, just over half of cancers are diagnosed at an early stage in England (54 per cent), and this proportion has not changed for almost a decade. Ms Mitchell said: 'It's fantastic to see that thanks to research, cancer death rates have drastically reduced over the last 50 years, and survival has doubled. 'However, there's more that can be done. This report highlights that over 460 people die from cancer every single day in the UK, and too many cases are diagnosed at a late stage. 'If we want to change that, we need bold action from the UK Government. 'The upcoming National Cancer Plan for England must improve cancer survival, and transform cancer services. 'If this plan is done right, it could save countless lives across England and ensure people affected by cancer live longer, better lives.' Cancer Research UK is calling for commitments such as the national rollout of a targeted lung cancer screening programme, quicker access to diagnostic tests for all patients, better access to GPs for speedy diagnosis and action to improve cancer waiting times. Its new study is the first ever to include 50 years of cancer death and incidence data for the UK. Elsewhere, MPs and members of the House of Lords have urged the Government to prioritise faster diagnosis of less survivable cancers, which are those that develop in the brain, pancreas, liver, lung, oesophagus and stomach. A new report from the All-Party Parliamentary Group (APPG) on Less Survivable Cancers claims these cancers claim 67,000 lives a year, around 42 per cent of cancer deaths. Doubling diagnoses rates in these areas could save an additional 7,500 lives a year, it said. Paulette Hamilton, chairwoman of the APPG on Less Survivable Cancers, said this is a 'crucial moment for transforming patient outcomes and accelerating survival rates for the less survivable cancers'. 'We're on the brink of research breakthroughs and in the midst of developing potentially game-changing Government health reforms,' she added. 'In this backdrop, achieving faster diagnosis for these devastating cancers is finally within reach.' Professor Peter Johnson, NHS national clinical director for cancer, said: 'The NHS is seeing and treating record numbers of people for cancer, with more people diagnosed at an earlier stage than ever before, and survival rates in England at an all-time high. 'We have developed world-leading programmes, including lung cancer screening in convenient locations such as car parks and using AI to spot skin cancer, making it easier than ever before to get checked. 'The latest data shows that more than three quarters of people received the all-clear or a definitive cancer diagnosis within four weeks of an NHS urgent cancer referral.'
Daily Mail
an hour ago
- Daily Mail
Prescription pill taken by 9million is linked to devastating motor neurone disease, researchers find
Antidepressants, taken by some 8.6 million people in the UK, could raise the risk of motor neurone disease, a major study has suggested. Scandinavian researchers also found that other commonly prescribed drugs, like anxiolytics used to treat anxiety disorders, sleeping pills and sedatives were also linked to an increased risk of the disabling condition. Motor neurone disease, of which amyotrophic lateral sclerosis (ALS) is the most common form, is an incurable, muscle-wasting condition that eventually stops a patient from being able to move, talk and even eat. Now, research has suggested that being prescribed any of these medications just twice over the course of a lifetime could raise the chance of developing the condition by up to 34 per cent. Scientists found the risk remained even if the drugs were taken more than five years before diagnosis. However other scientists have urged caution over the results of the study, suggesting the link lies with the fact mental health patients are more likely to develop MND, rather than medication. Professor Ammar Al-Chalabi, a specialist in complex disease genetics at King's College London warned: 'Association is not causation. That is especially important here. 'We already know that some of the genetic variants that nudge people towards schizophrenia for example, overlap with variants that nudge people towards ALS. 'It may not be use of the medication that increases ALS risk, but that the need for the medication is a signal that someone is already at increased genetic risk.' The authors of the study, from various Scandinavian institutions, note that depression, anxiety, and sleep disturbances have been shown to have 'detrimental effects' on brain cells, resulting in 'structural brain change concurrent with ALS'. MND, which includes ALS, is a progressive disease that affects around 5,000 adults in the UK, and was famously suffered by the physicist Stephen Hawking. In the study, which was conducted in Sweden, experts looked at 1,057 patients with an average age of 67, who were diagnosed with the disease between January 2015 and July 2023, as well as medications they had taken. Researchers followed the patients for an average of 1.33 years after their diagnosis. They matched these patients with a group of healthy controls to look for differences that could contribute to the disease. Writing in the journal JAMA open network, the researchers found prescribed use of anxiolytics was associated with 34 per cent increased risk of developing MND. Taking antidepressants, meanwhile, was linked with a 26 per cent raised chance, and sedatives and sleeping pills 21 per cent. The use of antidepressants pre-diagnosis in particular was also associated with a faster rate of functional decline. Lead author, Dr Charilaos Chourpiliadis, said that more work still needs to be done to understand the link. However, he said: 'Closer monitoring in younger patients with psychiatric symptoms might lead to an earlier ALS diagnosis.' Dr Brian Dickie, chief scientist at MND Association also flagged that the study may be flawed, because the most common genetic risk factor for ALS—a repeat expansion in the C9orf72 gene—is most prevalent in the Scandinavian population. 'A study in the Swedish population will most likely have a higher proportion of people with this particular genetic form of the disease,' he explained. 'Not only would higher use of psychiatric medication be likely, but this genetic form is also linked with faster progression and shorter survival, which could explain the association between psychiatric medication and more aggressive disease.'
The Independent
an hour ago
- The Independent
Fin removed from submarine as disposal reaches ‘significant marker'
A 'significant marker' in the progress of a submarine dismantling initiative has been completed, as the first vessel to be stripped down had its fin cut and removed. The Defence Nuclear Enterprise (DNE) submarine dismantling project announced on Wednesday that demonstrator sub Swiftsure has had its fin removed, a major milestone as the vessel prepares to be fully dismantled by the end of 2026. The work is the world's first full dismantling of a nuclear-powered submarine using a novel and environmentally-responsible method, and it is taking place in Rosyth Dockyard, Fife. The DNE said more than 500 tonnes of waste has been removed and recycled from the sub, and 90% of its total weight is expected to be recycled. With Swiftsure acting as a guinea pig, the DNE aims to develop a blueprint for the recycling of future decommissioned pressurised water reactor one subs. High quality steel taken from the first vessel is already being repurposed for future subs. The fin removal was delivered by the DNE alongside Babcock and Defence Equipment and Support's Defence Recycling and Disposals Team (DRDT). Lorraine Russell, senior responsible owner for the submarine disposals programme, said: 'The project showcases our commitment to sustainable disposal practices. 'By recycling materials wherever possible, we're ensuring these vessels that served the nation so well continue to provide value even after decommissioning.' Alistair Hughes, head of DRDT, said: 'This sustainable solution has shown how we can extract the maximum value from surplus assets and improve defence's supply-chain resilience, whilst ensuring national security and prosperity remains at the core of what we do.' Sir Chris Gardner, chief executive of the Submarine Delivery Agency, said: 'To see the fin of Swiftsure removed is a significant marker of progress in the DNE's submarine dismantling project. 'Our colleagues continue to work tirelessly alongside our industry partners in Rosyth to deliver a proven dismantling method using this demonstrator vessel. My thanks go to everyone involved in this ground-breaking work.' Scottish Secretary Ian Murray said: 'This is another fantastic example of how world-leading Scottish expertise plays such a vital role in the UK's defence. 'Around 25,600 jobs across Scotland are supported by an annual multi-billion-pound Ministry of Defence investment – with 200 highly-skilled roles in Rosyth involved in the submarine dismantling project. 'National security and environmental responsibility are at the heart of our commitment to act as a responsible nuclear operator – a technology which will play a key role in the UK Royal Navy's submarine fleet keeping us safe for years to come. 'Just this week as part of the strategic defence review (SDR), the Prime Minister came to Scotland to announce up to 12 new nuclear-powered attack subs, building on the £15 billion investment set out for the UK's sovereign nuclear warhead programme. 'Scotland has always been at the beating heart of the UK's defence and security and the SDR will restore Britain's readiness, deter our adversaries and help drive economic growth across the UK, as part of our Plan for Change.'
